A 14 day randomized, open label, cross over, single center, outpatient study of Depakote [Divalproex Sodium] delayed-release or Depakote sprinkle vs. divalproex sodium extended-release in child and adolescent patients with epilepsy

Trial Profile

A 14 day randomized, open label, cross over, single center, outpatient study of Depakote [Divalproex Sodium] delayed-release or Depakote sprinkle vs. divalproex sodium extended-release in child and adolescent patients with epilepsy

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2008

At a glance

  • Drugs Valproate semisodium (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 17 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top